8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile
TL;DR: 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile (CAS 304868-24-4) is a chemical compound with molecular formula C20H29N3O and molecular weight 327.23 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
8-butyl-3,3-dimethyl-6-piperidin-1-yl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile
Also Known As: 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile, 8-butyl-3,3-dimethyl-6-piperidin-1-yl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile, 8-butyl-3,3-dimethyl-6-piperidyl-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbon itrile, 5-butyl-9,9-dimethyl-3-(1-piperidyl)-8-oxa-4-azabicyclo[4.4.0]deca-2,4,11-triene-2-carbonitrile
| Molecular Formula | C20H29N3O |
|---|---|
| Molecular Weight | 327.23 g/mol |
| LogP | 4.13748 |
| Topological Polar Surface Area | 49.15 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Exact Mass | 327.23105 |
| Heavy Atoms | 24 |
| Complexity | 639.2645 |
Chemical Identifiers
| CAS Number | 304868-24-4 |
|---|---|
| SMILES | CCCCC1=NC(=C(C2=C1COC(C2)(C)C)C#N)N3CCCCC3 |
Product Overview
8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile (CAS 304868-24-4), with molecular formula C20H29N3O and molecular weight 327.23 g/mol. IUPAC: 8-butyl-3,3-dimethyl-6-piperidin-1-yl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile.
Chemical Property Profile of 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile
Property Insights of 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile
The XLogP value of 4.13748 indicates that 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 49.15 Ų, 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile has 0 hydrogen bond donor(s) and 4 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile?
The CAS number of 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile is 304868-24-4.
What is the molecular formula of 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile?
The molecular formula of 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile is C20H29N3O.
What is the molecular weight of 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile?
The molecular weight of 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile is 327.23 g/mol.
Where can I buy 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile?
You can request a quote for 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile?
Yes, KEHONG BIO provides custom synthesis services for 8-butyl-3,3-dimethyl-6-(piperidin-1-yl)-3,4-dihydro-1H-pyrano[3,4-c]pyridine-5-carbonitrile and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.